Boehringer Ingelheim

BI chief “regrets” Brexit, but continues to invest in UK
Pharmaforum
Thu, 04/18/19 - 11:05 am
UK
Brexit
Boehringer Ingelheim
PureTech, Boehringer partner to develop lymph node-targeting cancer immunotherapies
BioCentury
Thu, 04/18/19 - 09:50 am
Boehringer Ingelheim
PureTech
lymphatic targeting
GI cancers
Boehringer’s blockbuster Spiriva under pressure, profits down
Pharmaforum
Wed, 04/17/19 - 09:50 am
Boehringer Ingelheim
earnings
Spiriva
Boehringer Ingelheim buys MacroDel platform developer ICD Therapeutics
Pharmaceutical Business Review
Mon, 04/1/19 - 12:19 pm
Boehringer Ingelheim
MacroDel biologics
M&A
ICD Therapeutics
Hand over your Humira biosim launch plans; judge tells Boehringer in AbbVie patent fight
Fierce Pharma
Wed, 02/27/19 - 12:06 pm
AbbVie
Boehringer Ingelheim
Humira
biosimilars
Boehringer Ingelheim and 3BP Forge a Multi-Year Collaboration
BioSpace
Fri, 02/22/19 - 11:48 am
Boehringer Ingelheim
3B Pharmaceuticals
drug discovery
peptides
Boehringer Ingelheim and Lilly announce the CAROLINA cardiovascular outcome trial of Tradjenta met its primary endpoint of non-inferiority compared with glimepiride
Pharmaceutical Business Review
Fri, 02/15/19 - 10:13 am
Boehringer Ingelheim
Eli Lilly
glimepiride
linagliptin
Tradjenta
type 2 diabetes
clinical trials
Boehringer Ingelheim and IBM link up for blockchain-powered clinical trials in Canada
Fierce Biotech
Tue, 02/12/19 - 12:03 pm
Boehringer Ingelheim
IBM
Canada
blockchain
clinical trials
AbbVie loses bid to hoard documents in Humira patent fight with Boehringer
Fierce Pharma
Mon, 02/11/19 - 12:21 pm
Boehringer Ingelheim
AbbVie
biosimilars
Humira
patents
Boehringer taps BioMed X to source psychiatric disease research proposals
BioCentury
Sat, 01/19/19 - 06:20 pm
Boehringer Ingelheim
BioMed
drug discovery
psychiatric disease
Boehringer building out biologics manufacturing in China
BioPharma Dive
Thu, 01/17/19 - 11:59 pm
China
drug manufacturing
Boehringer Ingelheim
biologics
Bioharmony, Boehringer partner to develop antimicrobials
BioCentury
Tue, 01/15/19 - 11:57 pm
Boehringer Ingelheim
Bioharmony Therapeutics
antimicrobials
Down but Not Out: 10 Biggest Drug Trials That Saw Challenges in 2018
BioSpace
Fri, 12/21/18 - 12:10 pm
clinical trials
Takeda
Zinfandel Pharmaceuticals
pioglitazone
Alzheimer's disease
Boehringer Ingelheim
BI 409306
Merck
verubecestat
Celgene
MS
ozanimod
Incyte
ID01
melanoma
vTv Therapeutics
azeliragon
Roche
Tecentriq
Exelixis
colorectal cancer
JNJ
atabacestat
Sareptat Therapeutics
DMD
Exondys 51
Alkermes
ALKS-5461
clinical depression
Boehringer offloads an mTOR cancer drug as Xynomic plots a quick advance in the clinic
Endpoints
Fri, 12/21/18 - 10:15 am
Boehringer Ingelheim
R&D
Xynomic
mTOR
Boehringer employees go door-to-door delivering holiday hope to lung cancer patients
Fierce Pharma
Mon, 12/17/18 - 09:04 am
Boehringer Ingelheim
patients
lung cancer
Mylan, Biocon copy inches closer to challenging Sanofi's long-suffering Lantus
Fierce Pharma
Thu, 12/13/18 - 12:24 pm
Sanofi
Lantus
Eli Lilly
Boehringer Ingelheim
Mylan Labs
generics
diabetes
insulin
basal insulin
Boehringer Ingelheim plans to cut about 300 jobs in France
Yahoo/Reuters
Mon, 12/10/18 - 11:47 pm
France
Boehringer Ingelheim
layoffs
Boehringer dropping ex-U.S. biosimilars programs
BioCentury
Wed, 11/28/18 - 11:49 pm
Boehringer Ingelheim
biosimilars
Drug Approvals for the 2 Most Common Types of Cancer in the Last 2 Years
BioSpace
Mon, 11/19/18 - 11:29 am
cancer
breast cancer
lung cancer
drug approvals
AstraZeneca
Takeda
Ariad Pharmaceuticals
Merck
Pfizer
Novartis
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
Puma Biotechnology
Mylan
Genentech
Boehringer Ingelheim and Epizyme Ink Collaboration Deal With $15 Million Upfront and $280 Million in Biobucks
BioSpace
Thu, 11/15/18 - 10:46 am
cancer
R&D
drug development
Boehringer Ingelheim
Epizyme

Pages